Jacobsen Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
1,538
+1
+0.1% +$1.01K 0.48% 25
2025
Q4
$1.65M Sell
1,537
-1
-0.1% -$956 0.54% 23
2025
Q3
$1.17M Sell
1,538
-25
-2% -$18.6K 0.4% 24
2025
Q2
$1.22M Buy
1,563
+214
+16% +$166K 0.45% 24
2025
Q1
$1.11M Buy
1,349
+65
+5% +$54.1K 0.48% 22
2024
Q4
$991K Buy
1,284
+2
+0.2% +$1.66K 0.42% 24
2024
Q3
$1.14M Buy
1,282
+24
+2% +$21.6K 0.48% 21
2024
Q2
$1.14M Buy
1,258
+103
+9% +$82.4K 0.51% 20
2024
Q1
$899K Buy
1,155
+26
+2% +$18.5K 0.42% 23
2023
Q4
$658K Buy
1,129
+187
+20% +$109K 0.33% 29
2023
Q3
$506K Sell
942
-8
-0.8% -$4.12K 0.27% 36
2023
Q2
$446K Buy
+950
New +$398K 0.23% 44

Other funds holding LLY

Jacobsen Capital Management's LLY Position: Q1 2026 in Review

Jacobsen Capital Management increased its Eli Lilly (LLY) stake by 0.07% in Q1 2026, buying an estimated $1.01K and bringing the position to 1,538 shares worth $1.41M. The position accounts for 0.48% of the portfolio, ranked #25.

Jacobsen Capital Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.65M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jacobsen Capital Management held 1,538 shares of Eli Lilly worth $1.41M as of Q1 2026.
  • Jacobsen Capital Management bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.48% of Jacobsen Capital Management's portfolio in Q1 2026, its #25 holding.
  • Jacobsen Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Jacobsen Capital Management's Eli Lilly position peaked at $1.65M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jacobsen Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.